Avro Life Science

Avro Life Science develops skin patches that administer generic drugs through the skin and eliminate the need for oral medication. Their first product – an allergy patch for children – helps children avoid the negative side effects of taking oral medication (ie. trouble swallowing, forgetting to take medicine, etc.).

Operating in prime based in Waterloo, ON, Canada, Avro Life Science operates.

Profile

A clinical stage biotech redefining the skin’s potential as a target for novel first-in-class Therapies.

The company sits in the prime segment, where it competes on its core product or service.

Its base of operations is Waterloo, ON, Canada.

It is recorded at the Winter 2018 stage.

Its team size is recorded as 8 employees.

Website: avrolifesci.com